CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
7,506,584
Share change
+667,446
Total reported value
$42,486,000
Price per share
$5.66
Number of holders
41
Value change
+$3,109,298
Number of buys
32
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2018

As of 31 Dec 2018, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,506,584 shares. The largest 10 holders included Cortina Asset Management, LLC, Nantahala Capital Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, ARS Investment Partners, LLC, ROYCE & ASSOCIATES LP, ACUTA CAPITAL PARTNERS, LLC, SEGALL BRYANT & HAMILL, LLC, INGALLS & SNYDER LLC, and GAGNON SECURITIES LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.